Safety and efficacy of evobrutinib in relapsing multiple sclerosis (evolutionRMS1 and evolutionRMS2): two multicentre, randomised, double-blind, active-controlled, phase 3 trials

Xavier Montalbán, Patrick Vermersch, Douglas L. Arnold, Amit Bar-Or, Bruce Cree, Anne H. Cross, Eva Havrdová, Ludwig Kappos, Olaf Stüve, Heinz Wiendl, Jerry S. Wolinsky, Frank Dahlke, Claire Le Bolay, Li Shen Loo, Sathej Gopalakrishnan, Yann Hyvert, Andrija Javor, Hans Guehring, Nadia Tenenbaum, Davorka Tomic, Adriana Josefa Carra, Norma Haydee Deri, Jorge Gustavo Jose, Susana del Valle Liwacki, Carolina Natalia Mainella, Fatima Pagani, Guillermo Povedano, Alberto Rodriguez Alfici, Dario Raul Tavolini, Carlos Federico Buonanotte, Marcos Burgos, Juan Carlos Giugni, Juan Jose Martin Artesi, Juan Ignacio Rojas, Daniel Raul Zuin, Hugo Osvaldo Videla, Jorge Daniel Correale, Geraldine G. Luetic, Suzanne Hodgkinson, Jeannette Lechner-Scott, John Parratt, Noel Saines, Stephen Reddel, Tissa Wijeratne, Bruce Taylor, Florian Deisenhammer, Gerhard Traxler, Fritz Leutmezer, Peter Wipfler, Joerg R. Weber, Christian Lampl, Emmanuel Bartholome, Dominique Dive, Nele Glibert, Gaetano Perrotta, Vincent Pesch, Maarten Buyle, Bart Wijmeersch, Barbara Willekens, Edin Basagic, Enra Mehmedika Suljic, Inge Klupka-Sarić, Maya Danovska, Maria Dimitrova, Krasimir Genov, Alim Izmaylov, Radoslav Mavrov, Ivan Milanov, Valcho Naydenov, Penko Shotekov, Ivaylo Tarnev, Latchezar Traykov, Francois Emond, Daniel Selchen, Donald Rivest, Lisa Sabella, Ludivine Witkowski, Alexander Saveriano, Addinson Rene Bolano Solano, Cesar Augusto Franco Ruiz, Andrea Catalina Nassar Tobon, Carlos Alberto Navas Cardozo, Antonio Schlesenger, Javier Dario Triana, Osvaldo Elias Lara Sarabia, Luis Alfonso Zarco Montero, Jorge Andres Jimenez Arango, Silvio Basic, Marija Bosnjak Pasic, Silva Butkovic Soldo, Mario Habek, Spomenka Kidjemet-Piskac, Meri Matijaca, Vladimira Vuletic, Radek Ampapa, Michal Dufek, Marketa Grunermelova, Jan Mares, Alena Martinkova, Marek Peterka